264 related articles for article (PubMed ID: 28091608)
1. Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors.
Jakubík J; Randáková A; Zimčík P; El-Fakahany EE; Doležal V
Sci Rep; 2017 Jan; 7():40381. PubMed ID: 28091608
[TBL] [Abstract][Full Text] [Related]
2. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
[TBL] [Abstract][Full Text] [Related]
3. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
4. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
5. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
6. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
7. Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.
Prilla S; Schrobang J; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2006 Jul; 70(1):181-93. PubMed ID: 16641315
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors.
Jakubik J; El-Fakahany EE; Tucek S
J Biol Chem; 2000 Jun; 275(25):18836-44. PubMed ID: 10749854
[TBL] [Abstract][Full Text] [Related]
9. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
10. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors.
Lazareno S; Birdsall B; Fukazawa T; Gharagozloo P; Hashimoto T; Kuwano H; Popham A; Sugimoto M; Birdsall NJ
Life Sci; 1999; 64(6-7):519-26. PubMed ID: 10069518
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel and functionally selective non-competitive muscarinic antagonists as chemical probes.
Boulos JF; Jakubik J; Boulos JM; Randakova A; Momirov J
Chem Biol Drug Des; 2018 Jan; 91(1):93-104. PubMed ID: 28646631
[TBL] [Abstract][Full Text] [Related]
12. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor.
Jakubík J; Tucek S; El-Fakahany EE
J Pharmacol Exp Ther; 2002 Jun; 301(3):1033-41. PubMed ID: 12023535
[TBL] [Abstract][Full Text] [Related]
13. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
[TBL] [Abstract][Full Text] [Related]
14. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.
Lazareno S; Popham A; Birdsall NJ
Mol Pharmacol; 2000 Jul; 58(1):194-207. PubMed ID: 10860942
[TBL] [Abstract][Full Text] [Related]
15. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
Lanzafame AA; Sexton PM; Christopoulos A
Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
[TBL] [Abstract][Full Text] [Related]
16. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
17. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of methoctramine binding and selectivity at muscarinic acetylcholine receptors.
Jakubík J; Zimčík P; Randáková A; Fuksová K; El-Fakahany EE; Doležal V
Mol Pharmacol; 2014 Aug; 86(2):180-92. PubMed ID: 24870405
[TBL] [Abstract][Full Text] [Related]
19. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
Hu J; Wang SZ; Forray C; el-Fakahany EE
Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
[TBL] [Abstract][Full Text] [Related]
20. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
